Results 71 to 80 of about 24,471 (215)

Prevention of infectious diseases in athletes. [PDF]

open access: yes, 2007
The sports medicine physician may face challenging issues regarding infectious diseases when dealing with teams or highly competitive athletes who have difficulties taking time off to recover.
d'Hemecourt, Pierre, Luke, Anthony
core  

High prevalence of antibodies to human herpesvirus 8 in relatives of patients with classic Kaposi's sarcoma from Sardinia [PDF]

open access: yes, 1998
A survey for antibodies to a recombinant small viral capsid antigen (sVCA) of human herpesvirus type 8 (HHV‐8) was conducted in Sardinia, one of the world's highest incidence areas for classic Kaposi's sarcoma (KS). Prevalence of antibodies to HHV‐8 sVCA
Angeloni, Antonio   +11 more
core   +1 more source

Age at First RSV Hospitalisation and the Risk of Subsequent Bacterial Pneumonia

open access: yes
Acta Paediatrica, EarlyView.
Samuel Videholm   +4 more
wiley   +1 more source

The Current Landscape and Future Prospects of Vaccine Manufacturing in Africa: Challenges, Innovations, and Opportunities: A Narrative Review

open access: yesHealth Science Reports, Volume 9, Issue 3, March 2026.
ABSTRACT Background and Aims Africa has significant challenges in meeting its vaccination needs, including inadequate manufacturing capacity, infrastructure deficiencies, a scarcity of experienced personnel, regulatory hurdles, restricted access to technology and intellectual property.
Courage Chandipwisa   +3 more
wiley   +1 more source

Las vacunas conjugadas contra la enfermedad meningococica causadas por los serogrupos A, C, W-135, Y

open access: yesVacciMonitor, 2009
Review the current evidence on available and candidate quadrivalent meningococcal conjugate vaccines. Methods: A comprehensive overview of data on the currently available A-C-W135-Y meningococcal vaccine and the results of late stage development of novel
Marcos Aurelio P. Sáfadi
doaj  

Imaging of disease dynamics during meningococcal sepsis. [PDF]

open access: yesPLoS ONE, 2007
Neisseria meningitidis is a human pathogen that causes septicemia and meningitis with high mortality. The disease progression is rapid and much remains unknown about the disease process. The understanding of disease development is crucial for development
Hong Sjölinder, Ann-Beth Jonsson
doaj   +1 more source

EPI Update, March 25, 2011 [PDF]

open access: yes, 2011
Weekly newsletter for Center For Acute Disease Epidemiology of Iowa Department of Public ...

core  

Invasive meningococcal disease in the Veneto region of Italy: A capture-recapture analysis for assessing the effectiveness of an integrated surveillance system [PDF]

open access: yes, 2017
open8noBACKGROUND: Epidemiology of Neisseria meningitidis has been changing since the introduction of universal vaccination programmes against meningococcal serogroup C (MenC) and meningococcal serogroup B (MenB) has now become dominant.
Baldo, Vincenzo   +7 more
core   +1 more source

Healthcare Development, Relaxed Natural Selection, and COVID‐19 Infection Rates: An Evolutionary Population‐Level Analysis

open access: yesHealth Science Reports, Volume 9, Issue 3, March 2026.
ABSTRACT Background and Aim Evolutionary principles offer critical insights into pandemic dynamics but have been largely overlooked in contemporary responses to COVID‐19. Relaxed natural selection, increased global mobility, and lifestyle mismatches have contributed to human vulnerability to infectious diseases in modern societies.
Wenpeng You   +5 more
wiley   +1 more source

Validation of the Vaccination Confidence Scale: A Brief Measure to Identify Parents at Risk for Refusing Adolescent Vaccines [PDF]

open access: yes, 2016
Objective To validate a brief measure of vaccination confidence using a large, nationally representative sample of parents. Methods We analyzed weighted data from 9018 parents who completed the 2010 National Immunization Survey–Teen, an annual ...
Brewer, Joseph M.   +5 more
core   +3 more sources

Home - About - Disclaimer - Privacy